Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups Both of Moderna’s COVID-19 vaccines for the ...

Moderna Inc. (NASDAQ:MRNA) on Tuesday released preliminary immunogenicity data for the 2025-2026 formula of Spikevax, which targets the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19. The ...

According to the U.S. Food and Drug Administration (FDA), Spikevax is simply a new name for a product the public is already familiar with — the Moderna COVID-19 vaccine. Comirnaty is also just a new ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

A second COVID-19 vaccine has been granted full approval by the Food and Drug Administration (FDA). Spikevax, also known as the Moderna COVID-19 vaccine, has been approved for active immunization to ...

BIRMINGHAM, Ala. (WIAT) — Marketing changes by major COVID-19 vaccine manufacturers have people asking: What is Spikevax? What is Comirnaty? According to the U.S. Food and Drug Administration (FDA), ...